SCHEMBL23905958

SCHEMBL23905958

O=C1CCOc2c1ccc(OCc1ccncc1)c2-c1ccc(-c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 5/20 0.47
PIK3CD O00329 4/20 0.46
MAOB P27338 6/20 0.45
ALDH1A1 P00352 2/20 0.45
NPC1 O15118 1/20 0.45
HPGD P15428 1/20 0.45
NFKB1 P19838 1/20 0.45
RAB9A P51151 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
IKBKB O14920 1/20 0.40
CYP19A1 P11511 3/20 0.39
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
KDM4E B2RXH2 1/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23906313 0.80 MAOB (0.46) GRM5MAOBALDH1A1NPC1HPGD
SCHEMBL23905175 0.80 MRGPRX4 (0.47) GRM5MAOBALDH1A1NPC1HPGD
SCHEMBL23905999 0.78 GRM5 (0.42) GRM5PIK3CDMAOBALDH1A1NPC1
SCHEMBL23905984 0.78 LTB4R (0.47) GRM5MAOBALDH1A1NPC1HPGD
SCHEMBL23905943 0.77 GRM5 (0.41) GRM5MAOBALDH1A1NPC1HPGD
SCHEMBL23905925 0.76 LTB4R (0.59) GRM5MAOBALDH1A1NPC1HPGD
SCHEMBL30251291 0.75 MAPT (0.51) GRM5MAOBALDH1A1NPC1HPGD
SCHEMBL23882923 0.75 MAPT (0.51) GRM5MAOBALDH1A1NPC1HPGD
SCHEMBL20554658 0.75 MAOB (0.55) GRM5MAOBALDH1A1NPC1HPGD
SCHEMBL30132594 0.75 MAOB (0.55) GRM5MAOBALDH1A1NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198283-A1 INHIBITORS OF ANTIGEN PRESENTATION BY HLA-DR JANSSEN PHARMACEUTICA NV (BE) 2021-10-07 WO disclosed